Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor Shrinkage.

MLA

Jackson, Mark, et al. “Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor Shrinkage.” The Journal of Pharmacology and Experimental Therapeutics, vol. 385, no. 2, May 2023, pp. 106–16. EBSCOhost, https://doi.org/10.1124/jpet.122.001431.

APA

Jackson, M., Ahmari, N., Wu, J., Rizvi, T. A., Fugate, E., Kim, M.-O., Dombi, E., Arnhof, H., Boehmelt, G., Düchs, M. J., Long, C. J., Maier, U., Trapani, F., Hofmann, M. H., & Ratner, N. (2023). Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor Shrinkage. The Journal of Pharmacology and Experimental Therapeutics, 385(2), 106–116. https://doi.org/10.1124/jpet.122.001431

Chicago

Jackson, Mark, Niousha Ahmari, Jianqiang Wu, Tilat A Rizvi, Elizabeth Fugate, Mi-Ok Kim, Eva Dombi, et al. 2023. “Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor Shrinkage.” The Journal of Pharmacology and Experimental Therapeutics 385 (2): 106–16. doi:10.1124/jpet.122.001431.